Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
ROYAL Philips NV's US$1.7 billion deal to buy Spectranetics Corp, a US maker of devices to treat cardiac disease, shows the Dutch company is moving more aggressively to bolster its growing health-care business.
Philips will offer US$38.50 a share in cash for the Colorado